JP5172661B2 - 抗真菌剤 - Google Patents

抗真菌剤 Download PDF

Info

Publication number
JP5172661B2
JP5172661B2 JP2008511788A JP2008511788A JP5172661B2 JP 5172661 B2 JP5172661 B2 JP 5172661B2 JP 2008511788 A JP2008511788 A JP 2008511788A JP 2008511788 A JP2008511788 A JP 2008511788A JP 5172661 B2 JP5172661 B2 JP 5172661B2
Authority
JP
Japan
Prior art keywords
phenyl
oxo
indolizin
acetamide
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008511788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545647A (ja
JP2008545647A5 (enExample
Inventor
トムソン，サマンサ，パトリシア
デイヴィス，リアン，テレサ
アランソン，ニゲル，マーク
クフシノフ，アレクサンダー
デイヴィス，ギャレス，モース
エドワーズ，フィリップ，ニール
Original Assignee
エフ２ジー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0510190A external-priority patent/GB0510190D0/en
Priority claimed from GB0607841A external-priority patent/GB0607841D0/en
Application filed by エフ２ジー リミテッド filed Critical エフ２ジー リミテッド
Publication of JP2008545647A publication Critical patent/JP2008545647A/ja
Publication of JP2008545647A5 publication Critical patent/JP2008545647A5/ja
Application granted granted Critical
Publication of JP5172661B2 publication Critical patent/JP5172661B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2008511788A 2005-05-18 2006-05-18 抗真菌剤 Expired - Fee Related JP5172661B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0510190A GB0510190D0 (en) 2005-05-18 2005-05-18 Antifungal agents
GB0510190.2 2005-05-18
GB0607841.4 2006-04-20
GB0607841A GB0607841D0 (en) 2006-04-20 2006-04-20 Antifungal agents
PCT/GB2006/001820 WO2006123145A1 (en) 2005-05-18 2006-05-18 Antifungal agents

Publications (3)

Publication Number Publication Date
JP2008545647A JP2008545647A (ja) 2008-12-18
JP2008545647A5 JP2008545647A5 (enExample) 2009-07-02
JP5172661B2 true JP5172661B2 (ja) 2013-03-27

Family

ID=36763577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511788A Expired - Fee Related JP5172661B2 (ja) 2005-05-18 2006-05-18 抗真菌剤

Country Status (11)

Country Link
US (1) US8486962B2 (enExample)
EP (1) EP1888063B1 (enExample)
JP (1) JP5172661B2 (enExample)
AT (1) ATE420639T1 (enExample)
AU (1) AU2006248812B2 (enExample)
CA (1) CA2608977C (enExample)
DE (1) DE602006004865D1 (enExample)
DK (1) DK1888063T3 (enExample)
ES (1) ES2321230T3 (enExample)
NZ (1) NZ563397A (enExample)
WO (1) WO2006123145A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0623209D0 (en) * 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
GB0710121D0 (en) * 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
DE102007037579B4 (de) 2007-08-09 2012-05-16 Emc Microcollections Gmbh Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe
CN101168532B (zh) * 2007-11-30 2010-06-02 中科院嘉兴中心应用化学分中心 一种n-甲基哌嗪取代苯胺的合成方法
PL2283006T3 (pl) 2008-04-24 2015-08-31 F2G Ltd Pirolowe środki przeciwgrzybicze
GB0809773D0 (en) * 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
US20130102631A1 (en) 2010-07-02 2013-04-25 Syngenta Crop Protection Llc Novel microbiocidal dioxime ether derivatives
AR082405A1 (es) 2010-07-29 2012-12-05 Syngenta Participations Ag Derivados microbicidas de eteres de dioximas
EP2619181A1 (en) 2010-09-23 2013-07-31 Syngenta Participations AG Novel microbiocides
EP2638011A1 (en) 2010-11-12 2013-09-18 Syngenta Participations AG Novel microbiocides
WO2012117021A2 (en) 2011-03-03 2012-09-07 Syngenta Participations Ag Novel microbiocidal oxime ethers
AR087609A1 (es) 2011-08-23 2014-04-03 Syngenta Participations Ag Microbiocidas
WO2013092460A1 (en) 2011-12-20 2013-06-27 Syngenta Participations Ag Cyclic bisoxime microbicides
US20150025105A1 (en) * 2012-02-09 2015-01-22 Praveen Rao Perampalli Nekkar Indolizine derivatives
EP2641901A1 (en) 2012-03-22 2013-09-25 Syngenta Participations AG. Novel microbiocides
CN102964256B (zh) * 2012-11-28 2014-05-07 浙江海翔药业股份有限公司 一种4-氨基-n,n-二甲基苄胺的制备方法
CN104744302A (zh) * 2013-12-31 2015-07-01 上海药谷药业有限公司 一种2-(4-氨基苯基)-2-甲基丙腈化合物的制备方法
EP3415511A1 (en) * 2014-11-21 2018-12-19 F2G Limited Antifungal agents
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN112898316A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型吡咯化合物
CN114644634B (zh) * 2020-12-21 2023-06-20 深圳市祥根生物医药有限公司 一种吡咯衍生物及其制备方法和用途
CN114031502A (zh) * 2021-10-09 2022-02-11 南京一苇医药科技有限公司 一种对硝基苯丙酮的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT77867A (hu) * 1994-07-21 1998-09-28 Eli Lilly And Co. sPLA2-gátló indolizinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
WO2002098876A1 (en) * 2001-06-06 2002-12-12 Vertex Pharmaceuticals Incorporated Cak inhibitors and uses thereof
AU2004222387A1 (en) * 2003-03-13 2004-09-30 Synta Pharmaceuticals Corp. Fused pyrrole compounds

Also Published As

Publication number Publication date
US20080161302A1 (en) 2008-07-03
ATE420639T1 (de) 2009-01-15
CA2608977C (en) 2014-09-23
AU2006248812A1 (en) 2006-11-23
ES2321230T3 (es) 2009-06-03
DK1888063T3 (da) 2009-05-11
WO2006123145A1 (en) 2006-11-23
EP1888063B1 (en) 2009-01-14
DE602006004865D1 (de) 2009-03-05
NZ563397A (en) 2010-04-30
CA2608977A1 (en) 2006-11-23
JP2008545647A (ja) 2008-12-18
AU2006248812B2 (en) 2012-02-16
US8486962B2 (en) 2013-07-16
EP1888063A1 (en) 2008-02-20

Similar Documents

Publication Publication Date Title
JP5172661B2 (ja) 抗真菌剤
JP5712263B2 (ja) 抗真菌剤としての２−［（２−置換された）−インドリジン−３−イル］−２−オキソ−アセトアミド誘導体
KR20110031297A (ko) 항진균 조합 치료방법
EP2001468B1 (en) Thiazolidinedione analogues
KR20080012304A (ko) 피라졸 화합물 및 이들 피라졸 화합물을 포함하여이루어지는 당뇨병 치료약
CN113473978A (zh) 用于治疗皮肤疾病氰基芳烃-苯胺化合物
JP7302120B2 (ja) 線維症疾患の治療及び／又は予防用インドリン誘導体
US20110065723A1 (en) Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]-n-[3-(4-pyridyl)-1-[2-(4-pyridyl)ethyl]propyl]propanamide and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090514

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120515

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120809

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121115

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121211

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121226

R150 Certificate of patent or registration of utility model

Ref document number: 5172661

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees